Anacetrapib

Anacetrapib

Chembox new
ImageFile = Anacetrapib.svg
ImageSize =
IUPACName = (4"S",5"R")-5- [3,5-bis(trifluoromethyl)phenyl] -
3-{ [4'-fluoro-2'-methoxy-5'-(propan-2-yl)-4-
(trifluoromethyl) [1,1'-biphenyl] -2-yl] methyl}-
4-methyl-1,3-oxazolidin-2-one
OtherNames =
Section1 = Chembox Identifiers
CASNo = 875446-37-0
PubChem = 11556427
SMILES =

Section2 = Chembox Properties
Formula = C30H25F10NO3
MolarMass = 637.51 g·mol−1
Appearance =
Density =
MeltingPt =
BoilingPt =
Solubility =

Section3 = Chembox Hazards
MainHazards =
FlashPt =
Autoignition =

Anacetrapib (USAN,cite web | url = http://www.ama-assn.org/ama1/pub/upload/mm/365/anacetrapib.pdf | title = Statement on a nonproprietary name adopted by the USAN Council: Anacetrapib | year = 2007 | accessdate = 2008-01-19 | publisher = American Medical Association] pINN; codenamed MK-0859, Merck) is a CETP inhibitor being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease. It has been in Phase I clinical trials; preliminary results appear encouraging,cite journal |author=Krishna R, Anderson MS, Bergman AJ, "et al" |title=Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies |journal=Lancet |volume=370 |issue=9603 |pages=1907–14 |year=2007 |pmid=18068514 |doi=10.1016/S0140-6736(07)61813-3] although long-term safety data are lacking.

At the 16th International Symposium on Drugs Affecting Lipid Metabolism (New York, Oct 4-7, 2007), Merck reported on a Phase IIb study. The eight week study reported dosage correlated reduction in LDL-C and increases in HDL-C levels with no corresponding increases in blood pressure in any cohort. The increase in HDL was particularly significant, averaging 44 percent, 86 percent, 139 percent and 133 percent at doses of 10 mg, 40 mg, 150 mg and 300 mg.

ee also

*Torcetrapib, another CETP inhibitor unsuccessfully developed by Pfizer

References


Wikimedia Foundation. 2010.

Игры ⚽ Поможем решить контрольную работу

Look at other dictionaries:

  • Cholesterinester-Transferprotein — Bändermodell von CETP von zwei Seiten gesehen, nach PDB  …   Deutsch Wikipedia

  • Akutes Koronarsyndrom — Klassifikation nach ICD 10 I20.0 Instabile Angina pectoris I21 Akuter Myokardinfarkt …   Deutsch Wikipedia

  • Hypercholesterolemie — Hypercholestérolémie Par hypercholestérolémie (littéralement : cholestérolémie élevée) on entend un taux élevé de cholestérol sanguin. Ce n est pas une maladie en soi mais un trouble métabolique. En termes de santé publique, on parlera de… …   Wikipédia en Français

  • Hypercholestérolémie — Par hypercholestérolémie (littéralement : cholestérolémie élevée) on entend un taux élevé de cholestérol sanguin. Ce n est pas une maladie en soi mais un trouble métabolique. En termes de santé publique, on parlera de facteur de risque. Son… …   Wikipédia en Français

  • Hypocholestérolémiant — Hypercholestérolémie Par hypercholestérolémie (littéralement : cholestérolémie élevée) on entend un taux élevé de cholestérol sanguin. Ce n est pas une maladie en soi mais un trouble métabolique. En termes de santé publique, on parlera de… …   Wikipédia en Français

  • High-density lipoprotein — High density lipoproteins (HDL) is one of the 5 major groups of lipoproteins (chylomicrons, VLDL, IDL, LDL, HDL) which enable lipids like cholesterol and triglycerides to be transported within the water based blood stream. In healthy individuals …   Wikipedia

  • Niacin — IUPAC name …   Wikipedia

  • Statin — This article is about the group of cholesterol lowering drugs. For the amino acid, see Statine. Lovastatin, a compound isolated from Aspergillus terreus, was the first statin to be marketed. Statins (or HMG CoA reductase inhibitors) are a class… …   Wikipedia

  • Hypolipidemic agent — Hypolipidemic agents, or antihyperlipidemic agents, are a diverse group of pharmaceuticals that are used in the treatment of hyperlipidemias. They are called lipid lowering drugs (LLD) or agents. Contents 1 Classes of hypolipidemic drugs 1.1… …   Wikipedia

  • Simvastatin — Systematic (IUPAC) name …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”